News for 'drug money'

Trade generics growth to dent value expansion of domestic drug market

Trade generics growth to dent value expansion of domestic drug market

Rediff.com2 Jan 2024

Rising penetration of trade generic medicines is eating into the value growth of the domestic pharmaceutical market, showed a recent analysis. According to a Kotak Institutional Equities analysis, 70-110 basis points (bps) annual dent is expected from trade generics and Jan Aushadhi on Indian Pharma Market (IPM) growth at least until FY27-28 (see chart). Trade generic medicines are those that are not pushed into the market through doctor promotions.

Drug bust off Kerala: Court sends Pak national to NCB custody till May 27

Drug bust off Kerala: Court sends Pak national to NCB custody till May 27

Rediff.com24 May 2023

The NCB had sought custody of Zubair Derakshshandeh for five days from May 22, said advocate B A Aloor who is representing the accused in the case.

NCB gets custody of Pakistani national in 2500 kg drug seizure off Kerala

NCB gets custody of Pakistani national in 2500 kg drug seizure off Kerala

Rediff.com16 May 2023

A court in Kochi granted the Narcotics Control Bureau 14-day custody of the Pakistani national arrested in connection with the seizure of over 2,500 kg of methamphetamine from a vessel in Indian waters off the port city.

US drug shortage a shot in the arm for Indian pharmaceutical companies

US drug shortage a shot in the arm for Indian pharmaceutical companies

Rediff.com26 Jun 2023

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Nuvama Research analysts said that US price erosion seems to have normalised to its old levels of 6-8 per cent and volumes are picking up with easing of inventory. Similarly, an ICICIdirect analyst noted: "Price erosion intensity has now moderated to a single digit and is expected to tone down a

'Tariffs will hurt insurance, patients and everyone'

'Tariffs will hurt insurance, patients and everyone'

Rediff.com10 Feb 2025

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like basis, Siddharth Mittal, chief executive officer (CEO) and managing director, Biocon, told Sohini Das/Business Standard in a virtual interaction that local manufacturing in the US is a trade off between cost and qualifying to do business there.

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).

US drug shortage, stable pricing set to boost pharma revenues

US drug shortage, stable pricing set to boost pharma revenues

Rediff.com24 Jul 2023

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India's pharmaceutical companies during the first quarter of this financial year, analysts said. Most brokerages estimate a top line growth of around 14-15 per cent, with earnings before interest, taxes, depreciation, and amortisation (Ebitda) growth of 24-30 per cent for Q1 of FY24. Hospitals are, however, likely to report lower occupancy rates, and diagnostics companies may witness an impact from delayed monsoon.

'We Have Begged For Justice'

'We Have Begged For Justice'

Rediff.com12 Mar 2025

'Justice may or may not happen, but who are those people who did this to her?' 'If the hospital authorities had helped us that day, or the police, then the real culprits would have been caught.' 'Getting justice for my daughter is my goal now and I want the CM to remember that.'

Drug case accused Lalit Patil held in Bengaluru, claims he was made to run

Drug case accused Lalit Patil held in Bengaluru, claims he was made to run

Rediff.com18 Oct 2023

He was on Wednesday produced before a magistrate in suburban Andheri which remanded him in police custody till October 23 in the same mephedrone seizure case.

India hopes for temporary tariff waiver as US official comes calling

India hopes for temporary tariff waiver as US official comes calling

Rediff.com24 Mar 2025

India and the United States will finalize the contours, schedule of negotiations, and terms of reference for a proposed bilateral trade agreement (BTA) during a three-day meeting beginning Tuesday. The agreement is expected to be finalized in two tranches, with the first phase focusing on goods trade. The US team, led by Assistant US Trade Representative for South and Central Asia Brendan Lynch, will be in India from March 25-29 to discuss the agreement. Both countries are aiming to conclude the first phase of the agreement by fall 2025.

Taiwanese among 17 held in Gujarat for 'digital arrest' fraud

Taiwanese among 17 held in Gujarat for 'digital arrest' fraud

Rediff.com14 Oct 2024

Seventeen persons, including four hailing from Taiwan, were arrested by Ahmedabad Cyber Crime Branch for allegedly operating a nationwide 'digital arrest' racket, a Gujarat police official said on Monday.

US reciprocal tariffs to have limited impact on India: S&P

US reciprocal tariffs to have limited impact on India: S&P

Rediff.com19 Feb 2025

S&P Global Ratings on Wednesday said the impact of the US reciprocal tariff will be limited on India as the economy is domestically oriented with less reliance on exports. YeeFarn Phua, Director, Sovereigns and International Public Finance Ratings, Asia-Pacific S&P Global also said India will clock a 6.7-6.8 per cent GDP growth over the next two years.

Mutual Funds Emerge As Financiers For M&A Deals

Mutual Funds Emerge As Financiers For M&A Deals

Rediff.com6 Feb 2025

'Growth for some companies has been hard to come by and this is a smart way to get there.'

How to avoid digital arrest scams? Govt issues advisory

How to avoid digital arrest scams? Govt issues advisory

Rediff.com7 Oct 2024

The advisory depicted the logos of social media platforms like WhatsApp and Skype to showcase that calls for such scams are made using such platforms.

Parents, Equip Your Child For A Changing World

Parents, Equip Your Child For A Changing World

Rediff.com19 Dec 2024

'Make your child solve his/her problems on his/her own. Let the child see parenting as a partnership between you and your child.'

Budget focuses on domestic consumption amid global uncertainties

Budget focuses on domestic consumption amid global uncertainties

Rediff.com4 Feb 2025

The Budget 2025-26 meets the expectations of fiscal consolidation, maintaining capital expenditure, and boosting consumption through tax cuts.

Amit Shah virtually witnesses destruction of 30,000 kg of drugs

Amit Shah virtually witnesses destruction of 30,000 kg of drugs

Rediff.com30 Jul 2022

Over 30,000 kg of drugs were incinerated in four locations across India on Saturday in the virtual presence of Union Home Minister Amit Shah.

Budget 2025: Grassroot Level Implementation Is Necessary

Budget 2025: Grassroot Level Implementation Is Necessary

Rediff.com5 Feb 2025

Simplifying investment policies at the micro level and introducing a time-bound framework will be critical for India's growth targets, notes Krishna Ella.

Several irregularities in Aryan Khan drugs case: NCB report

Several irregularities in Aryan Khan drugs case: NCB report

Rediff.com18 Oct 2022

The inquiry flagged "suspicious behaviour" of seven to eight officers of the NCB.

'Murderers Are The Most Reliable People'

'Murderers Are The Most Reliable People'

Rediff.com19 Feb 2025

'It would be difficult for us to run jails if it wasn't for murderers.'

Jt drugs controller waives trial of Biocon drug; arrested

Jt drugs controller waives trial of Biocon drug; arrested

Rediff.com21 Jun 2022

The CBI has arrested Joint Drugs Controller S Eswara Reddy for allegedly receiving a Rs 4 lakh bribe to waive the phase three clinical trial of the Insulin Aspart injection, a product of Biocon Biologics under development to manage Type 1 and Type 2 diabetes, officials said on Tuesday. Biocon Biologics is a subsidiary of the Kiran Mazumdar Shaw-led Biocon. The company has denied allegations. The agency has also arrested Dinesh Dua, director at Synergy Network India Private Limited, who was allegedly giving Reddy a bribe, they said.

Court asks NCB to file new affidavit in 2500 kg drug bust off Kerala coast

Court asks NCB to file new affidavit in 2500 kg drug bust off Kerala coast

Rediff.com23 May 2023

The court was considering the petition of the NCB seeking the custody of Pakistan national accused Zubair Derakshshandeh for five days from today.

Budget 2025: More Jobs Via Thriving Farms and MSME Growth

Budget 2025: More Jobs Via Thriving Farms and MSME Growth

Rediff.com4 Feb 2025

The most striking features of this Budget was its focus on simplification and improving the ease of doing business in India, asserts Kaku Nakhate.

Jimmy Carter's India Connection

Jimmy Carter's India Connection

Rediff.com9 Jan 2025

Lillian Carter, a trained nurse and a Peace Corps worker, spent two years of her life, when she was in her late 60s, serving the poor in India, in the 1960s. She was posted as a volunteer to Vikhroli, then a village 30 km outside of Mumbai and a Godrej township, and was there from 1966 to 1968.

34 new drugs added to 'essential medicines' list, 26 dropped

34 new drugs added to 'essential medicines' list, 26 dropped

Rediff.com14 Sep 2022

As many as 34 new drugs were added to and 26 dropped from an updated list of essential medicines on Tuesday, with the government saying this will reduce "patients' out-of-pocket expenditure". The National List of Essential Medicines (NLEM 2022) has 384 drugs, up from 376 in 2015. "Drafting this list is a lengthy process, and around 350 experts from across India have held over 140 consultation meetings to draft the NLEM 2022," Union Health Minister Mansukh Mandaviya said.

Despite short-term blip, Sun Pharma remains favourite among investors

Despite short-term blip, Sun Pharma remains favourite among investors

Rediff.com28 Dec 2024

Around six weeks ago, Sun Pharmaceutical Industries, India's largest drugmaker, suffered a setback, which led to a selloff in the share. The US District Court of New Jersey granted Incyte's request for a preliminary injunction against Sun Pharma's launch of Leqselvi, a drug that treats alopecia.

Drug sales stuck at pre-pandemic level, price rise shapes market growth

Drug sales stuck at pre-pandemic level, price rise shapes market growth

Rediff.com16 May 2023

Drug sale volumes are almost stuck at pre-pandemic levels but price growth has improved value, data from market research agency Pharmarack AWACS showed. The Indian pharmaceutical market's (IPM) volumes in April 2023 grew by 0.21 per cent when compared to April 2019. Key therapy areas like cardiac, anti-diabetic and vitamins recorded negative volume or consumption growth, while respiratory, anti-infectives, and pain and analgesics had positive growth from April 2019 to April this year.

Of Trump's reciprocal tariffs and trade deals

Of Trump's reciprocal tariffs and trade deals

Rediff.com14 Feb 2025

Of Trump's reciprocal tariffs and trade deals

Avoid Mini Trade Deal With US

Avoid Mini Trade Deal With US

Rediff.com13 Feb 2025

The Budget has given signals that India is sensitive to the US needs and willing to walk the extra mile, but if need be, we should respond in equal measure as a sovereign nation, notes Ajay Srivastava.

Major terror threat to India from ISIS, Al Qaeda in J-K: FATF

Major terror threat to India from ISIS, Al Qaeda in J-K: FATF

Rediff.com20 Sep 2024

It said a "sudden rise" in terrorist-financing investigations was seen in 2023 and this was attributed to events arising out of incidents in Manipur that led to such probes in more than 50 cases.

'We Know How To Protect Our Religion'

'We Know How To Protect Our Religion'

Rediff.com18 Nov 2024

'If someone fiddles us on our religion then we will pay back five times more to that person. We have proved that time and again.'

Telegram founder Durov barred from leaving France

Telegram founder Durov barred from leaving France

Rediff.com29 Aug 2024

Pavel Durov, the founder and CEO of Telegram, is under formal investigation related to illicit activities on the messaging app.

Sun Pharma recalls over 34k bottles of generic drug in US

Sun Pharma recalls over 34k bottles of generic drug in US

Rediff.com11 Feb 2023

Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing. As per the US Food and Drug Administration's Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling lots of Diltiazem Hydrochloride extended-release capsules which are used to treat angina, high blood pressure and some types of irregular heartbeats.

Kuki-Meitei divide deepens as chaos reigns in Manipur

Kuki-Meitei divide deepens as chaos reigns in Manipur

Rediff.com31 Dec 2024

Manipur experienced a year of intense turmoil in 2024, marked by escalating violence, displacement, and deepening divisions between the Meitei community in the valley and the Kuki tribes in the hills. The conflict, rooted in historical grievances and fueled by political tensions, resulted in numerous casualties, mob attacks, and drone strikes on civilian areas. The situation has led to widespread displacement, fear, and a sense of insecurity among the affected communities, with no signs of peace in sight.

Covid drug sales shine even as market slows

Covid drug sales shine even as market slows

Rediff.com18 Aug 2020

Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation.

Aus Open PIX: Djokovic survives scare; Alcaraz cruises

Aus Open PIX: Djokovic survives scare; Alcaraz cruises

Rediff.com13 Jan 2025

Novak Djokovic was seriously rattled early on by inspired American teenager Nishesh Basavareddy but rallied for a 4-6, 6-3, 6-4, 6-2 victory on Monday.

UK's richest 10% took half of wealth from India during colonialism

UK's richest 10% took half of wealth from India during colonialism

Rediff.com20 Jan 2025

The United Kingdom extracted USD 64.82 trillion from India over a century of colonialism between 1765 and 1900 and USD 33.8 trillion of this went to the richest 10 per cent -- enough money to carpet London in notes of 50 British pound almost four times over.

Terrorism common threat, need decisive measures to counter it: BRICS leaders

Terrorism common threat, need decisive measures to counter it: BRICS leaders

Rediff.com23 Oct 2024

In a joint declaration issued after the 16th BRICS Summit in the Russian city of Kazan attended by Prime Minister Narendra Modi and Chinese President Xi Jinping, among others, the leaders reiterated unequivocal condemnation of terrorism in all its forms and manifestations while reaffirming that it should not be associated with any religion, nationality, civilisation or ethnic group.

ED files case against YouTuber Elvish Yadav over snake venom use

ED files case against YouTuber Elvish Yadav over snake venom use

Rediff.com4 May 2024

The central agency has pressed charges under the Prevention of Money Laundering Act after taking cognisance of a FIR and charge sheet filed by the Gautam Buddh Nagar (Noida) district police in Uttar Pradesh last month against him and other linked to him.

Pill Review: Impressive Riteish!

Pill Review: Impressive Riteish!

Rediff.com12 Jul 2024

Riteish Deshmukh makes this medical drama watchable! exclaims Namrata Thakker.